Sir Allen McClay, founder of Northern Ireland-based pharmaceutical services company the Almac Group, has transferred part of his ownership of the company to a new charitable trust, the McClay Foundation.
Sir Allen McClay, founder of Northern Ireland-based pharmaceutical services company the Almac Group, has transferred part of his ownership of the company to a new charitable trust, the McClay Foundation.
Almac will now be jointly owned by Mr McClay, its chairman, and the McClay Foundation. The Foundation has been set up to promote the use of diagnostic tools and drugs...
The new US FDA vaccine guidelines introduced on 20 May might cause financial woes for Moderna, but overall vaccine makers should not be as impacted as feared.
The Phase II study testing the novel TLR7/8 inhibitor met the primary endpoint in a cohort of patients with cutaneous lupus erythematosus and systemic lupus erythematosus with rash, but did not in patients with SLE.
Coming one day after Boehringer’s underwhelming data, PureTech’s tweaked molecule, deupirfenidone, shows promise in slowing idiopathic pulmonary fibrosis.
